Are you Dr. Ellsworth?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 30 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
550 University Blvd
Indianapolis, IN 46202Phone+1 317-944-2524- Is this information wrong?
Summary
- Dr. Susannah Ellsworth, MD is a radiation oncologist in Indianapolis, Indiana. She is currently licensed to practice medicine in Indiana, Pennsylvania, and Maryland. She is affiliated with UPMC Presbyterian Shadyside.
Education & Training
- University of MarylandResidency, Radiation Oncology, 2006 - 2010
- University of MarylandInternship, Internal Medicine, 2005 - 2006
- University of Maryland School of MedicineClass of 2005
Certifications & Licensure
- PA State Medical License 2020 - 2024
- IN State Medical License 2015 - 2021
- MD State Medical License 2011 - 2016
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Start of enrollment: 2013 Jan 01
- Chemoradiation or Brachytherapy for Rectal Cancer Start of enrollment: 2014 Jun 12
- Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region Start of enrollment: 2016 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsDeclarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology.Susannah G Ellsworth, Peter S N van Rossum, Radhe Mohan, Steven H Lin, Clemens Grassberger, Brian Hobbs> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Dec 1
- RE: Venkatesulu et al. (Letter to the Editor).Susannah G Ellsworth, Radhe Mohan, Steven H Lin> ;Radiotherapy and Oncology. 2023 Apr 1
- 1 citationsNeoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.Aaron J Grossberg, Krishan R Jethwa, Susannah G Ellsworth> ;JAMA Oncology. 2023 Feb 1
- Join now to see all
Hospital Affiliations
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania